Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 92 of 1,261
  1. US 12097230

    Method and composition for treating post operative conditions

    Bright Green Corporation Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  2. US 12097291

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  3. US 12098155

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  4. US 12098385

    Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

    The Regents of the University of California Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  5. US 12098138

    Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases

    The Board of Regents of the University of Texas System Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  6. US 12097290

    Membrane encapsulated nanoparticles and method of use

    The Regents of the University of California Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  7. US 12098116

    Crystalline prostacyclin (IP) receptor agonist and uses thereof

    United Therapeutics Corporation Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  8. US 12098215

    Fusion protein construct

    Northwestern University Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  9. US 12098118

    Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction

    Regents of the University of Minnesota Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  10. US 12098144

    Piperazine indazole glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  11. US 12097306

    Conformal coating of biological surfaces

    Takeda Pharmaceutical Company Limited Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  12. US 12097223

    Mesenchymal stromal cells and uses related thereto

    Astellas Institute for Regenerative Medicine Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  13. US 12097196

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  14. US 12097263

    Muscle targeting complexes and uses thereof for treating myotonic dystrophy

    Dyne Therapeutics, Inc. Β· Granted Sep 24, 2024 Β· Expires Sep 19, 2044

    granted
  15. US 2024307628

    SYSTEMS AND METHODS FOR DELIVERY OF LIQUID PHARMACEUTICAL COMPOSITIONS IN PARTICULAR COMPRISING ONE OR MORE SGLT-2 INHIBITOR(S)

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] Β· Granted Sep 19, 2024 Β· Expires Sep 14, 2044

    granted
  16. WO 2024188803

    PRODUCTION DE POXVIRUS Γ€ PARTIR DE CULTURES DE CELLULES DE CAILLE

    BAVARIAN NORDIC AS [DK] Β· Granted Sep 19, 2024 Β· Expires Sep 14, 2044

    granted
  17. WO 2024188802

    PROCÉDÉS D'ISOLEMENT DE POXVIRUS À PARTIR DE CULTURES DE CELLULES AVIAIRES

    BAVARIAN NORDIC AS [DK] Β· Granted Sep 19, 2024 Β· Expires Sep 14, 2044

    granted
  18. WO 2024188801

    UTILISATION DE LIGNÉES CELLULAIRES DE CAILLE POUR PRODUCTION DE POXVIRUS

    BAVARIAN NORDIC AS [DK] Β· Granted Sep 19, 2024 Β· Expires Sep 14, 2044

    granted
  19. US 12090206

    Compositions comprising tri- and penta-block synthetic copolypeptide hydrogels

    The Regents of the University of California Β· Granted Sep 17, 2024 Β· Expires Sep 12, 2044

    granted
  20. US 12090126

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. Β· Granted Sep 17, 2024 Β· Expires Sep 12, 2044

    granted
  21. US 12089574

    Humanized skeletal muscle

    Regents of the University of Minnesota Β· Granted Sep 17, 2024 Β· Expires Sep 12, 2044

    granted
  22. US 12090140

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. Β· Granted Sep 17, 2024 Β· Expires Sep 12, 2044

    granted
  23. US 12091661

    Organic compositions to treat HSF1-related diseases

    Arrowhead Pharmaceuticals, Inc. Β· Granted Sep 17, 2024 Β· Expires Sep 12, 2044

    granted
  24. US 12090175

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California Β· Granted Sep 17, 2024 Β· Expires Sep 12, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.